← Leaderboards
David M Anderson
University Of Washington
$21,829,168
Attributed
$21,829,168
Total exposure
69
Grants
42
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.2M · FY2005–19$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$128,858,719 · 74
By mechanism
P51$110,662,827 · 60
U24$6,623,843 · 7
C06$5,700,000 · 2
U42$5,454,047 · 3
P01$343,350 · 1
R13$74,652 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Shiu-Lok Hu$65,602,557
- Juan Bonifacino$3,443
- Marjorie Robert-Guroff$2,142,617
- Charlotte Hotchkiss$10,673,162
- Craig Phillip Chappell$158,550
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesFundingGrantUnited States National Institutes Of HealthPrimatesAnimalsInstitutionResearch PersonnelSourceNonhuman PrimateVaccinesVirusWashingtonComputer Retrieval Of Information On Scientific Projects DatabaseAnimal CareBreedingImmunologyAcquired Immunodeficiency SyndromeProgramsMacacaEnsureHousingOperationSubfamily Lentivirinae
Grant awards (104)
Washington National Primate Research Center$12,859,589
P51 · FY2019 · OD · contact PI
Washington National Primate Research Center$499,999
P51 · FY2019 · OD · contact PI
Supplement to support investigations of neurobiology of aging in a monkey model$308,142
P51 · FY2019 · OD · contact PI
Washington National Primate Research Center$12,859,589
P51 · FY2018 · OD · contact PI
Washington National Primate Research Center$455,761
P51 · FY2018 · OD · contact PI
Washington National Primate Research Center$345,250
P51 · FY2018 · OD · contact PI
Washington National Primate Research Center$12,859,589
P51 · FY2017 · OD · contact PI
Washington National Primate Research Center$498,548
P51 · FY2017 · OD · contact PI
Washington National Primate Research Center$12,859,589
P51 · FY2016 · OD · contact PI
Washington National Primate Research Center$97,253
P51 · FY2016 · OD · contact PI
Washington National Primate Research Center$12,795,503
P51 · FY2015 · OD · contact PI
Washington National Primate Research Center$655,914
P51 · FY2015 · OD · contact PI
Washington National Primate Research Center$497,960
P51 · FY2015 · OD · contact PI
Washington National Primate Research Center$250,000
P51 · FY2015 · OD · contact PI
Washington National Primate Research Center$12,924,750
P51 · FY2014 · OD · contact PI
Washington National Primate Research Center$499,987
P51 · FY2014 · OD · contact PI
Washington National Primate Research Center$12,728,728
P51 · FY2013 · OD · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY$1,844,673
U42 · FY2011 · RR · contact PI
SVEU HOLDING$492,946
P51 · FY2011 · RR · contact PI
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES$377,899
P51 · FY2011 · RR · contact PI
COMPARISON OF VACCINE REGIMENS: HIV-SIV RECOMBINANTS WITH PROTEIN BOOSTING$377,899
P51 · FY2011 · RR · contact PI
POST-EXPOSURE MONITORING OF LENTIVIRUS-INFECTED MACAQUES$377,899
P51 · FY2011 · RR · contact PI
MECHANISM OF PROTECTIVE IMMUNITY INDUCED BY EBOLA VACCINES$156,634
P51 · FY2011 · RR · contact PI
29th Annual Symposium for Nonhuman Primate Models for AIDS$74,652
R13 · FY2011 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY$1,804,687
U42 · FY2010 · RR · contact PI
WaNPRC Macaca nemestrina SPF Breeding Colony$1,804,687
U42 · FY2010 · RR · contact PI
POST-EXPOSURE MONITORING OF LENTIVIRUS-INFECTED MACAQUES$465,257
P51 · FY2010 · RR · contact PI
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES$465,257
P51 · FY2010 · RR · contact PI
MECHANISM OF PROTECTIVE IMMUNITY INDUCED BY EBOLA VACCINES$155,086
P51 · FY2010 · RR · contact PI
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS$497,090
P51 · FY2009 · RR · contact PI
POST-EXPOSURE MONITORING OF LENTIVIRUS-INFECTED MACAQUES$331,393
P51 · FY2009 · RR · contact PI
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES$331,393
P51 · FY2009 · RR · contact PI
SVEU HOLDING$331,393
P51 · FY2009 · RR · contact PI
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS$422,135
P51 · FY2008 · RR · contact PI
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES$422,135
P51 · FY2008 · RR · contact PI
LONG-TERM SURVIVORS OF SIV/HIV INFECTION$422,135
P51 · FY2008 · RR · contact PI
SVEU HOLDING$422,135
P51 · FY2008 · RR · contact PI
SVEU HOLDING$500,123
P51 · FY2007 · RR · contact PI
IN VIVO ENHANCEMENT OF SHIV896P PATHOGENCITY IN M FASCICULARIS$434,135
P51 · FY2007 · RR · contact PI
ALPHAVIRUS-BASED HIV VACCINE COMPARISON$434,135
P51 · FY2007 · RR · contact PI
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS$434,135
P51 · FY2007 · RR · contact PI
LONG-TERM SURVIVORS OF SIV/HIV INFECTION$434,135
P51 · FY2007 · RR · contact PI
IMMUNOGENICITY IN MACAQUES OF A DNA/OLIGOMERIC ENVELOPE PROTEIN HIV VACCINE$434,134
P51 · FY2007 · RR · contact PI
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY$1,095,130
U24 · FY2006 · RR · contact PI
LONG-TERM SURVIVORS OF SIV/HIV INFECTION$293,779
P51 · FY2006 · RR · contact PI
SVEU HOLDING$293,779
P51 · FY2006 · RR · contact PI
RESEARCH SPECIMEN COLLECTION$293,779
P51 · FY2006 · RR · contact PI
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES II$293,779
P51 · FY2006 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY: AIDS: INDONESIA$261,757
U24 · FY2006 · RR · contact PI
IMMUNOGENICITY IN MACAQUES OF A DNA/OLIGOMERIC ENVELOPE PROTEIN HIV VACCINE$228,467
P51 · FY2006 · RR · contact PI
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS$228,467
P51 · FY2006 · RR · contact PI
ALPHAVIRUS-BASED HIV VACCINE COMPARISON$228,467
P51 · FY2006 · RR · contact PI
IN VIVO ENHANCEMENT OF SHIV896P PATHOGENCITY IN M FASCICULARIS$228,467
P51 · FY2006 · RR · contact PI
ALPHAVIRUS-BASED HIV VACCINE COMPARISON$228,467
P51 · FY2006 · RR · contact PI
IMMUNOGENICITY IN MACAQUES OF A DNA/OLIGOMERIC ENVELOPE PROTEIN HIV VACCINE$228,467
P51 · FY2006 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY: AIDS: HIV IMMUNOLOGY$166,679
U24 · FY2006 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY: AIDS: ANIMAL MODEL$166,679
U24 · FY2006 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY: AIDS: THERAPEUTIC AGENT DVMT$166,679
U24 · FY2006 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY: AIDS: VACCINE DVMT$166,679
U24 · FY2006 · RR · contact PI
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY: AIDS: HIV GENOME$166,657
U24 · FY2006 · RR · contact PI
SPECIAL CLINICAL CASES$132,006
P51 · FY2006 · RR · contact PI
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY$1,219,119
U24 · FY2005 · RR
SPECIFIC PATHOGEN FREE BREEDING COLONY$614,542
P51 · FY2005 · RR
RESEARCH SPECIMEN COLLECTION$249,042
P51 · FY2005 · RR
IN VIVO ENHANCEMENT OF SHIV896P PATHOGENCITY IN M FASCICULARIS$177,333
P51 · FY2005 · RR
ALPHAVIRUS-BASED HIV VACCINE COMPARISON$175,831
P51 · FY2005 · RR
IMMUNOGENICITY OF A MICROPARTICLE DNA/OLIGOMERIC ENVELOPE PROTEIN HIV VACCINE$175,831
P51 · FY2005 · RR
EVALUATION OF SECONDARY CTL RESPONSE FOLLOWING CHALLENGE WITH SIV$175,831
P51 · FY2005 · RR
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS$175,831
P51 · FY2005 · RR
SVEU HOLDING$175,831
P51 · FY2005 · RR
WANPRC SEMINAR SERIES$120,732
P51 · FY2005 · RR
VISITING SCIENTIST PROGRAM$102,588
P51 · FY2005 · RR
SPECIAL CLINICAL CASES$90,512
P51 · FY2005 · RR
RESEARCH REVIEW COMMITTEE$38,261
P51 · FY2005 · RR
Extramural Research Facilities Improvement Program Proj*$3,700,000
C06 · FY2004 · RR
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY$1,124,742
U24 · FY2004 · RR
SPECIFIC PATHOGEN FREE BREEDING COLONY$475,987
P51 · FY2004 · RR
RESEARCH SPECIMEN COLLECTION$228,544
P51 · FY2004 · RR
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES II$228,544
P51 · FY2004 · RR
EVALUATION OF SECONDARY CTL RESPONSE FOLLOWING CHALLENGE WITH SIV$228,544
P51 · FY2004 · RR
EFFICACY OF SIV VACCINE PREPARED W/ DIFFERENT ADJUVANTS$228,544
P51 · FY2004 · RR
SVEU HOLDING$228,045
P51 · FY2004 · RR
SPECIAL CLINICAL CASES$111,746
P51 · FY2004 · RR
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY$956,922
U24 · FY2003 · RR
EVALUATION OF SECONDARY CTL RESPONSE FOLLOWING CHALLENGE WITH SIV - LETVIN$189,414
P51 · FY2003 · RR
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS$189,414
P51 · FY2003 · RR
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES$189,414
P51 · FY2003 · RR
SVEU HOLDING$141,415
P51 · FY2003 · RR
SPECIAL CLINICAL CASES$100,927
P51 · FY2003 · RR
SPECIFIC PATHOGEN FREE BREEDING COLONY$90,834
P51 · FY2003 · RR
EVALUATION OF A NOVEL PROTEIN FOR THROMBUS PREVENTION IN AN ART. INJURY MODEL$50,463
P51 · FY2003 · RR
RESEARCH SPECIMEN COLLECTION$50,463
P51 · FY2003 · RR
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM$2,000,000
C06 · FY2002 · RR
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY$1,132,800
U24 · FY2002 · RR
CORE--NONHUMAN PRIMATE$0
P01 · FY2002 · AI
FIBROCYTES AS ANTIGEN PRESENTING CELLS FOR AIDS VACCINES$0
P51 · FY2001 · RR
ACUTE PATHOGENESIS FOLLOWING INOCULATION OF HIV 2287 IN M NEMESTRINA$0
P51 · FY2001 · RR
MUCOSAL TITRATION OF HIV 2 IN M NEMESTRINA$0
P51 · FY2001 · RR
CORE--NONHUMAN PRIMATE$0
P01 · FY2001 · AI
EFFICACY OF EXPERIMENTAL ANTI RETROVIRAL DRUGS IN MACAQUES W/ AIDS$0
P51 · FY2001 · RR
INOCULATION OF PAPIO SPP W/ HIV 2UC9429$0
P51 · FY2001 · RR
CORE--NONHUMAN PRIMATE$343,350
P01 · FY2000 · AI
FIBROCYTES AS ANTIGEN PRESENTING CELLS FOR AIDS VACCINES$132,406
P51 · FY2000 · RR
INOCULATION OF PAPIO SP W/ HIV 2UC9429$132,400
P51 · FY2000 · RR